Track 12: Combination & Conjugate Vaccines


Progressively, more sicknesses are getting antibody preventable, yet keeping up network and supplier acknowledgment requests that the quantity of infusions doesn't increment. Blend conjugate antibodies speak to an inescapable and significant development. This paper surveys the adequacy and security of mix conjugate antibodies, including immunological instruments hidden cooperation’s among immunization epitopes, the job of immunological memory, and relates of invulnerability. Explicit consideration is given to the involvement in blend antibodies against each of Haemophilus influenza type b, Streptococcus pneumonia and Neisseria meningitidis. The ramifications of these discoveries for various networks are examined, key zones for further research recognized and suggestions for post-licensure checking tended to.


  • Yellow fever
  • OPV Vaccine

Related Conference of Track 12: Combination & Conjugate Vaccines

September 07-08, 2026

38th Annual Congress on Vaccine and Clinical Trials

London, UK
September 21-22, 2026

44th Euro Global Summit and Expo on Vaccines & Vaccination

Barcelona, Spain
September 28-29, 2026

8th World Congress on Vaccine and Immunology

Toronto, Canada
November 16-17, 2026

7th International Conference on Vaccine Research

Tokyo, Japan

Track 12: Combination & Conjugate Vaccines Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in